Disopyramide Sustained-Release Capsules and Ranibizumab Intraocular
Determining the interaction of Disopyramide Sustained-Release Capsules and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Disopyramide Sustained-Release Capsules-Ranibizumab ophthalmic
- Disopyramide Sustained-Release Capsules-Ranitidine
- Disopyramide Sustained-Release Capsules-Ranitidine Capsule
- Disopyramide Sustained-Release Capsules-Ranitidine Hydrochloride
- Disopyramide Sustained-Release Capsules-Ranitidine Injection
- Disopyramide Sustained-Release Capsules-Ranitidine Suspension
- Ranibizumab Intraocular-DisperMox
- Ranibizumab Intraocular-Disposable Enema rectal
- Ranibizumab Intraocular-Disulfiram
- Ranibizumab Intraocular-Dithol Solution
- Ranibizumab Intraocular-Ditropan
- Ranibizumab Intraocular-Ditropan XL